| 1 |
Ramanathan S, Brilot F, Irani SR, Dale RC. Origins and immunopathogenesis of autoimmune central nervous system disorders. Nat Rev Neurol 2023;19:172-90. [PMID: 36788293 DOI: 10.1038/s41582-023-00776-4] [Reference Citation Analysis]
|
| 2 |
Räuber S, Schroeter CB, Strippel C, Nelke C, Ruland T, Dik A, Golombeck KS, Regner-Nelke L, Paunovic M, Esser D, Münch C, Rosenow F, van Duijn M, Henes A, Ruck T, Amit I, Leypoldt F, Titulaer MJ, Wiendl H, Meuth SG, Meyer Zu Hörste G, Melzer N. Cerebrospinal fluid proteomics indicates immune dysregulation and neuronal dysfunction in antibody associated autoimmune encephalitis. J Autoimmun 2023;135:102985. [PMID: 36621173 DOI: 10.1016/j.jaut.2022.102985] [Reference Citation Analysis]
|
| 3 |
Chen X, Fang L, Peng F, Wang Y, Dai Z, Wang J, Shu Y, Qiu W. Serum neurofilament light chain is associated with disturbed limbic-based functional connectivity in patients with anti-NMDAR encephalitis. J Neurochem 2023;164:210-25. [PMID: 36184969 DOI: 10.1111/jnc.15700] [Reference Citation Analysis]
|
| 4 |
Sabet MF, Barman S, Beller M, Meuth SG, Melzer N, Aktas O, Goebels N, Prozorovski T. Myelinating Co-Culture as a Model to Study Anti-NMDAR Neurotoxicity. Int J Mol Sci 2022;24. [PMID: 36613687 DOI: 10.3390/ijms24010248] [Reference Citation Analysis]
|
| 5 |
Shimohama S, Iizuka T, Takizawa T, Watanabe N, Tezuka T, Matsuda K, Yamanoi K, Kanazawa N, Kawamura Y, Yoshikawa T, Suzuki T, Takao M, Nakahara J, Izawa Y. Anti‐N‐methyl‐D‐aspartate receptor encephalitis with concurrent human herpes virus‐6A deoxyribonucleic acid detection: An autopsy case. Neuropathology 2022. [DOI: 10.1111/neup.12881] [Reference Citation Analysis]
|
| 6 |
Chang H, Ma J, Feng K, Feng N, Wang X, Sun J, Guo T, Wei Y, Xu Y, Wang H, Yin L, Zhang X. Elevated blood and cerebrospinal fluid biomarkers for microglial activation and blood- brain barrier disruption in anti-NMDA receptor encephalitis.. [DOI: 10.21203/rs.3.rs-2134324/v1] [Reference Citation Analysis]
|
| 7 |
Akanuma H, Iizuka T, Abe D, Yoshida K, Matsuda N, Sugimoto K, Hashimoto Y, Kanai K. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with small cell lung cancer and cytotoxic T-cell-mediated pathology: Case report. Front Immunol 2022;13:952868. [DOI: 10.3389/fimmu.2022.952868] [Reference Citation Analysis]
|
| 8 |
Höftberger R, Lassmann H, Berger T, Reindl M. Pathogenic autoantibodies in multiple sclerosis - from a simple idea to a complex concept. Nat Rev Neurol 2022. [PMID: 35970870 DOI: 10.1038/s41582-022-00700-2] [Reference Citation Analysis]
|
| 9 |
Torres FI, Pena FF, Santana VM, Atiaja JMC. Digital panels in the development of graphomotor skills in children from 3 to 5 years old. Ambato Ecuador. 2022 International Conference on Electrical, Computer and Energy Technologies (ICECET) 2022. [DOI: 10.1109/icecet55527.2022.9872972] [Reference Citation Analysis]
|
| 10 |
Winklehner M, Bauer J, Endmayr V, Schwaiger C, Ricken G, Motomura M, Yoshimura S, Shintaku H, Ishikawa K, Tsuura Y, Iizuka T, Yokota T, Irioka T, Höftberger R. Paraneoplastic Cerebellar Degeneration With P/Q-VGCC vs Yo Autoantibodies. Neurol Neuroimmunol Neuroinflamm 2022;9:e200006. [DOI: 10.1212/nxi.0000000000200006] [Reference Citation Analysis]
|
| 11 |
Hansen N. Immunopsychiatry – Innovative Technology to Characterize Disease Activity in Autoantibody-Associated Psychiatric Diseases. Front Immunol 2022;13:867229. [DOI: 10.3389/fimmu.2022.867229] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 12 |
Smets I, Titulaer MJ. Antibody Therapies in Autoimmune Encephalitis. Neurotherapeutics. [DOI: 10.1007/s13311-021-01178-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 13 |
Radosevic M, Planagumà J, Mannara F, Mellado A, Aguilar E, Sabater L, Landa J, García-serra A, Maudes E, Gasull X, Lewis M, Dalmau J. Allosteric Modulation of NMDARs Reverses Patients' Autoantibody Effects in Mice. Neurol Neuroimmunol Neuroinflamm 2022;9:e1122. [DOI: 10.1212/nxi.0000000000001122] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
